AXIOS September 24, 2021
Generic drug companies have asked Pfizer, Moderna and Johnson & Johnson to license their COVID-19 vaccine technology to help increase global production, but so far the vaccine makers have given them the cold shoulder.
Why it matters: Other companies are saying they have extra capacity to make more vaccines. Not using that extra capacity could prolong the pandemic throughout the world.
What they’re saying: “Right now our biggest problem is that we cannot produce enough vaccine to meet the high demand,” Moderna CEO Stéphane Bancel told a Swiss newspaper this week.
Behind the scenes: Several generics manufacturers have reached out to Pfizer, Moderna and Johnson & Johnson, and “none of their offers have been met positively,” said one industry source,...
Today's Sponsors
Today's Sponsor